IMRN

Immuron Ltd

• Reuters·03/05 16:05

  Emerging Growth Research reiterates Buy-Extended on Immuron with $3.90 price target

• Reuters·03/05 11:00

  Immuron CEO Steven Lydeamore to Present Virtually at Coffee Microcaps Conference

• Reuters·03/02 11:10

  Immuron HY26 net loss narrows 22.9% to AUD 1.9 million

• Benzinga·02/25 13:26

  Immuron H1 EPS $(0.01), Same YoY, Sales $4.184M Up From $3.994M YoY

• Seeking Alpha·02/25 11:14

  Immuron reports 1H results

• Reuters·02/25 11:00

  IMMURON LTD: TAKEN A STRATEGIC DECISION TO PURSUE PARTNERSHIPS TO FUND PROGRESS OF TRAVELAN AND IMM-529 CLINICAL PROGRAMS

• Reuters·02/17 13:02

  Immuron Limited Receives A$1.12 Million R&D Tax Incentive

• Reuters·02/12 13:01

  Immuron Limited Held Extraordinary General Meeting

• Reuters·01/26 06:51

  Immuron Limited Publishes Transcript of CEO Presentation at Emerging Growth Conference

• Reuters·01/22 11:00

  Emerging Growth Research Maintains Buy-Extended Rating on Immuron Limited With $3.50 Price Target

• TipRanks·01/20 12:27

  Immuron Reports Continued Travelan Sales Growth and ProIBS Launch in H1 FY26

• Benzinga·01/20 08:29

  Reported Monday, Immuron Reports Continued Sales Growth With H1 Global Sales Of AUD$4.2M, Up 5%, Driven By Travelan And ProIBS Launch

• Reuters·01/19 14:25

  BRIEF-Immuron Reports H1 Global Travelan Sales AUD$4.2 Mln

• Reuters·01/19 11:00

  Immuron Limited Reports 5% Increase in Global H1 Sales

• Reuters·01/19 11:00

  IMMURON LTD - H1 GLOBAL TRAVELAN SALES AUD$4.2 MLN